N/A N=3 Diagnostic

Indocyanine Green (ICG) and SPY Imaging for Assessment of Burn Healing

Burns

Bottom Line

View on ClinicalTrials.gov: NCT02766244 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Jun 2016

Primary outcome: Primary: Perfusion of Burned Area — 200; 100; 205; 180 % perfusion compared to normal skin

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: ICG/SPY (Device); Antibiotic Ointment (Drug)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Texas Tech University Health Sciences Center
Primary completion: Jul 2014

Outcome Measures

Outcome	Result	p-value
PRIMARY Perfusion of Burned Area	200; 100; 205; 180; 205; 110	—

Summary

Three patients were recruited for assessment of ICG fluorescence in burns.

Eligibility Criteria

Inclusion Criteria

patients with burn less than 15% TBSA

Exclusion Criteria

none

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02766244). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.